Supplements / medicine · 28 Aug 2026
Reframing sarcopenia as a disease of the ageing motor system
Source: The Lancet Healthy Longevity
What the research found
Commentary (personal view). A Lancet Healthy Longevity essay argues that age-related strength loss is not only shrinking muscle tissue. Trials of anabolic drugs or protein that raised lean mass often yielded modest function gains, while resistance training can improve strength and performance even when mass barely changes—because it also loads neural circuits, coordination, and blood flow. The piece favors progressive resistance work, balance, and motor-learning tasks over mass-only targets. Educational context, not a clinic protocol and not a claim that any supplement treats sarcopenia.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34